Clinical Trial Update: TB006 for Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of TB006 for Autism Spectrum Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• TB006

Snippet

Sponsor: Rossignol Medical Center | Conditions: Autism Spectrum Disorder | Phase 2 | Status: RECRUITING